Cantor Fitzgerald downgraded Gossamer Bio (GOSS) to Neutral from Overweight.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GOSS:
- Bracing for Stagflation? These 2 Stocks Offer Mouth-Watering Upside
- Gossamer Bio’s Seralutinib Future in Doubt After PROSERA Miss in PAH Raises FDA, Funding and Viability Risks
- Gossamer Bio reports Q4 EPS (21c), consensus (20c)
- Stagflation Risk Is Back — These 3 Stocks Can Help Defend Your Portfolio
- Gossamer Bio options imply 46.1% move in share price post-earnings